Women are emerging as major users of doctor-led glucagon-like peptide-1 (GLP-1) weight management programmes being offered by metabolic health startups in India, according to industry executives, with the surge largely fuelled by patients seeking support for polycystic ovary syndrome (PCOS), postpartum recovery and menopause. Lifestyle changes are also driving women to opt for such programmes, they said.While startups such as General